risks of glp 1 inhibitors Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia The GLP-1 Agonists and Obesity:

Understanding that weight regain is a biological response rather than personal failure is essential for patients and clinicians

doi:10.1056/NEJMoa2032183 Mehta A, Marso SP, Neeland IJ

Will I still get hungry

Here are some key situations where GLP-1 medications should be avoided and your doctor may recommend a different approach: Personal or family history of certain thyroid cancers: People with a history of thyroid cancer or multiple endocrine neoplasia type 2 (MEN 2) are generally advised not to use GLP-1s due to a potential increased risk of thyroid tumors

doi: 10.1056/NEJMoa2407379 21 AronneLJHornDBle RouxCWHoWFalconBLValderasEGet al

Step 2: Medical Intake and Provider Review